As an HRHR clinical trial participant, you play a vital role in advancing medical therapies that can improve countless lives – starting with your own. If you meet the criteria for a specific trial, you’ll receive a thorough medical screening that provides valuable information about your health. Throughout the process, you’ll always have access to a physician and care team whose first priority is your comfort and safety.
Currently Enrolling Trials
Endometriosis
Females, 18-50 years of age.
This clinical trial is to evaluate bone mineral density with long-term use of Relugolix combination tablet (Myfembree). This is an oral medication (taken by mouth). Currently, this medication is FDA approved for 2-year use, and this trial will study the medication taken during 4 years, and follow changes in bone mineral density for 1 year after treatment has stopped.
Eligibility
- MUST have a medical diagnosis of endometriosis.
- MUST have pain and heavy menstrual bleeding.
- Cannot have a diagnosis of major depressive disorder, bipolar depression, PTSD, or schizophrenia.
Trial Duration
5 year trial with appointments occurring approximately every 6 months.
Compensation
$125 per appointment and $75 per phone call.
Apply to this trial
Hypercholesterolemia
Males and females, 18+ years of age
Health Research of Hampton Roads is looking for males and females 18 years of age and older to participate in a high cholesterol clinical trial. This trial is to evaluate the efficacy (how well the drug works in lowering cholesterol) and safety of Merck drug, MK-0616 in individuals at high cardiovascular risk.
Eligibility
- Must be taking a cholesterol medication
- Must have elevated cholesterol numbers
- Must have had a heart attack OR stroke OR have type 2 diabetes & high blood pressure
Trial Duration
This trial will be about 4.5 years long (potentially a maximum of 6 years), and you will have up to 18 visits & 12 phone calls
Compensation
$100 per completed appointment | $25 per completed phone call
Apply to this trial
Weight Loss (On a Wait List)
Males and females, 18-80 years of age
We are looking for individuals aged 18-80 years old to participate in a Regeneron weight loss clinical trial. This study is researching trevogrumab and garetosmab in combination with another drug, semaglutide (commonly known as Wegovy). This trial will offer trevogrumab, garetosmab, and Wegovy either alone or in different combinations with each other. Trevogrumab and garetosmab are both monoclonal antibodies.
Eligibility
- Cannot have had a previous weight loss surgery
- Cannot have a diagnosis of Type I or Type II diabetes
- Must be willing to self-inject medication (with training)
- Must be willing to receive an IV infusion
Trial Duration
Approximately 20 month long trial with 15 in-office appointments and 9-13 appointments to Mary Immaculate Hospital for imaging
Compensation
$105 per completed office appointment | Additional $50 for IV infusion appointments
Apply to this trialWant to know more about upcoming trials?
We're regularly conducting trials for a variety of health conditions. If you'd like to be informed about future opportunities to participate, join our no-obligation mailing list.
